The New Oscaleta Partners Llc Holding in Naturalnano, Inc
Oscaleta Partners Llc filed with the SEC SC 13G form for Naturalnano, Inc. The form can be accessed here: 000107878216003871. As reported in Oscaleta Partners Llc’s form, the filler as of late owns 9.99% or 334,232 shares of the -company.
Naturalnano, Inc stake is a new one for the and it was filed because of activity on November 25, 2016. We feel this shows Oscaleta Partners Llc’s positive view for the stock.
NaturalNano, Inc. (NaturalNano) is a nanomaterials company. The Company develops and markets technologies and products that provide properties to a range of materials, such as industrial polymers, plastics and composites. The Company operates through two segments: Nanotechnology and ViralProtec. The Nanotechnology segment includes the development and commercialization of material additives based on a technology utilizing halloysite nanotubes (HNTs). The Nanotechnology segment is engaged in research, development, production and marketing of its technologies relating to the treatment and separation of nanotubes from halloysite clay and the development of related commercial applications for cosmetics, health and beauty products. The ViralProtec segment is a reseller for Ebola personal protective equipment (PPE) and ancillary supplies. The Company provides personal protective equipment for caregivers for infectious patient care.
SEC Form 13G is required when the filer owns between (5% and 20%) of a company and plans to hold it only as a passive investor. In case the filler intend to exert control and the stake’s exceeds 20%, then 13D Form must be filed. These filings can NOT be a precursor to “change of control” events such as hostile takeovers, company breakups or others.
It is down 25.00% since May 2, 2016 and is downtrending. It has underperformed by 30.26% the S&P500.
NaturalNano, Inc. is a nanomaterials company. The company has a market cap of $63,170. The Firm develops and markets technologies and products that provide properties to a range of materials, such as industrial polymers, plastics and composites. It currently has negative earnings. The Firm operates through two divisions: Nanotechnology and ViralProtec.
More notable recent Naturalnano Inc (OTCMKTS:NNAN) news were published by: Syracuse.com which released: “Onondaga County judgments: December 21 to 24” on January 05, 2016, also Reuters.com with their article: “Factbox: Companies working on ‘liquid biopsy’ for cancer” published on November 09, 2010, Prnewswire.com published: “The World Market for Cancer Diagnostics, 5th Edition: Precision and …” on May 05, 2014. More interesting news about Naturalnano Inc (OTCMKTS:NNAN) were released by: Prnewswire.com and their article: “The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition” published on August 06, 2012 as well as Prnewswire.com‘s news article titled: “Next Generation Cancer Diagnostics: Technologies and Global Markets” with publication date: September 04, 2014.
NNAN Company Profile
NaturalNano, Inc. (NaturalNano), incorporated on February 18, 2000, is a nanomaterials company. The Firm develops and markets technologies and products that provide properties to a range of materials, such as industrial polymers, plastics and composites. The Firm operates through two divisions: Nanotechnology and ViralProtec. The Company’s product, Pleximer, is a halloysite nanotube (HNT) polymer concentrate, in pellet form, that can be added directly into a polymer extruder.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.